Nytricx Intellectual Property
Issued IP
- Nitric oxide releasing packaging membranes. US Patent 10,494,493. December 3, 2019
- Mesoporous nitric oxide-releasing silica particles, methods of making, and uses thereof. US Patent 11,117,808. September 14, 2021
- Nitric oxide-releasing antibiotics, methods of making, and methods of use. US Patent 11,220,516. January 11,2022
- Surfaces and compositions having antifouling, antithrombotic, and antibacterial properties and methods of making. US Patent 11,370,934. June 28, 2022
- Nitric Oxide releasing surfaces for decreased fouling, thrombosis, and infection of medical devices. US Patent 12,016,974 B2. June 25, 2024
- Disinfection device. US Patent D1,066,723. March 11, 2025
Pending Wound IP
- Antibacterial wound treatments with clot-promoting properties. Priority date February 26, 2019. PCT/US2020/019701 filed Feb 25, 2020. WO 2020/176507 A1, September 3, 2020
- Nitric oxide-releasing disinfection insert. Priority date May 19, 2021. PCT/US2022/30045 filed May 19, 2022. Pending examination in Europe, US, and China. WO 2022/246075 A1, Nov 24, 2022.
- Phototriggerable nitric oxide-releasing compositions and applications thereof. Priority date Oct 13, 2022. PCT/18/485,737 filed Oct 12, 2023. US 2024/0139385 A1, May 2, 2024
- 30 additional patents pending (non wound related)
Nytricx acquired an exclusive license from The University of Georgia for the above IP on 1/12/22
